Exicure Falls $400K Short of Nasdaq’s $2.5M Equity Requirement, Faces Notice
XCUR•Exicure reported stockholders’ equity of approximately $2.1 million for Q1 2026, falling $400 k short of Nasdaq’s $2.5 million minimum requirement, prompting a non-compliance notice on June 5, 2026. The biotech company has until July 20, 2026, to file a compliance plan and may seek a 180-day extension while pursuing cost reductions and strategic alternatives.
1. Nasdaq Notice Details
On June 5, 2026, Exicure received a notification from Nasdaq indicating non-compliance with Listing Rule 5550(b)(1), which mandates a minimum stockholders’ equity of $2.5 million for companies on the Nasdaq Capital Market.
2. Equity Shortfall Causes
The company reported stockholders’ equity of approximately $2.1 million for the quarter ended March 31, 2026, reflecting executive separation expenses and obligations under long-term consulting arrangements established prior to the current management team’s appointment.
3. Remediation Plan and Timeline
Under Nasdaq rules, Exicure has 45 calendar days, until July 20, 2026, to submit a plan to regain compliance. If accepted, Nasdaq may grant up to a 180-day extension from the notice date to meet the equity requirement.
4. Strategic Initiatives
To address the shortfall, Exicure has implemented significant cost-reduction and restructuring initiatives, including terminating non-essential legacy consulting arrangements, and is exploring strategic alternatives to maximize stockholder value.
